Envoy Current Deferred Revenue from 2010 to 2026
| COCH Stock | 0.52 0.14 21.21% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter -142.2 K | Current Value -135.1 K | Quarterly Volatility 71.6 K |
Check Envoy Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Envoy Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.3 K, Other Operating Expenses of 11.9 M or Total Operating Expenses of 11.3 M, as well as many indicators such as Price To Sales Ratio of 258, Dividend Yield of 0.0729 or Days Sales Outstanding of 1.3 K. Envoy financial statements analysis is a perfect complement when working with Envoy Medical Valuation or Volatility modules.
Envoy | Current Deferred Revenue | Build AI portfolio with Envoy Stock |
The Current Deferred Revenue trend for Envoy Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Envoy Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Envoy Medical's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Envoy Medical over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Envoy Medical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Envoy Medical's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Envoy Current Deferred Revenue Regression Statistics
| Arithmetic Mean | (23,429) | |
| Geometric Mean | 25,704 | |
| Coefficient Of Variation | (305.54) | |
| Mean Deviation | 58,773 | |
| Median | 15,000 | |
| Standard Deviation | 71,585 | |
| Sample Variance | 5.1B | |
| Range | 173K | |
| R-Value | (0.73) | |
| Mean Square Error | 2.6B | |
| R-Squared | 0.53 | |
| Significance | 0.0009 | |
| Slope | (10,304) | |
| Total Sum of Squares | 82B |
Envoy Current Deferred Revenue History
About Envoy Medical Financial Statements
Investors use fundamental indicators, such as Envoy Medical's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Envoy Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -142.2 K | -135.1 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Envoy Medical Correlation against competitors. For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is there potential for Health Care Equipment & Supplies market expansion? Will Envoy introduce new products? Factors like these will boost the valuation of Envoy Medical. Projected growth potential of Envoy fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Envoy Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Envoy Medical requires distinguishing between market price and book value, where the latter reflects Envoy's accounting equity. The concept of intrinsic value - what Envoy Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Envoy Medical's price substantially above or below its fundamental value.
It's important to distinguish between Envoy Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Envoy Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Envoy Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.